Alison J. Moskowitz

Response to Comment on: “Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications”

Not available.

Classic Hodgkin Lymphoma

Importance Hodgkin lymphoma (HL) is a lymphoid malignancy derived from B cells. Globally, there were 82 409 new cases of HL in 2022, associated with 22 701 deaths. In the US, 8720 incident cases of HL and 1150 deaths due to HL were reported in 2025. Classic HL (cHL) accounts for...